NCT00033020

Brief Summary

The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
390

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Apr 2001

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2001

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

April 5, 2002

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 8, 2002

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2003

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2003

Completed
Last Updated

January 12, 2017

Status Verified

April 1, 2010

Enrollment Period

1.8 years

First QC Date

April 5, 2002

Last Update Submit

January 11, 2017

Conditions

Substance-Related Disorders

Keywords

substance use disorders

Outcome Measures

Primary Outcomes (3)

  • ASI

  • Opioid and cocaine use

  • AIDS risk behavior

Interventions

Behavior TherapyBEHAVIORAL

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Recent admission to an opioid substitution (methadone maintenance) CTP. Completed at least 4 weeks of maintenance at time of study entry
  • Evidence of cocaine or methamphetamine use Minimum of one documented positive urine within 2 weeks of study entry. For those exiting a controlled environment, any stimulant use within two weeks of entering the controlled environment

You may not qualify if:

  • Unable to give informed consent (fails simple consent quiz)
  • Answers yes to question: Are you in recovery from gambling? That is, have you stopped gambling because of previous gambling problems?

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Aegis Medical Systems, Inc.

Bakersfield, California, 93301 4709, United States

Location

Oasis Clinic

Washington D.C., District of Columbia, 20002, United States

Location

Glenwood Life Counseling Center

Baltimore, Maryland, 21212, United States

Location

Lower Eastside Service Center (LESC)

New York, New York, 10007, United States

Location

Greenwich House, Inc.

New York, New York, 10014, United States

Location

ACT

Philadelphia, Pennsylvania, 19141, United States

Location

Charleston Center

Charleston, South Carolina, 29403, United States

Location

Related Links

MeSH Terms

Conditions

Substance-Related Disorders

Interventions

Behavior Therapy

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Maxine Stitzer, Ph.D.

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Purpose
TREATMENT
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 5, 2002

First Posted

April 8, 2002

Study Start

April 1, 2001

Primary Completion

February 1, 2003

Study Completion

February 1, 2003

Last Updated

January 12, 2017

Record last verified: 2010-04

Locations

US(7)